Other trials, including EMPEROR-Reduced, EMPEROR-Preserved, and EMPACT-MI, showed trends in the same direction but did not reach statistical significance individually.
← all excerpts
Effect of Empagliflozin on Cardiovascular Mortality and Heart Failure Hospitalizations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
1
—
—